Roth Capital Raises Price Target on MaxLinear (MXL) Following 3Q Results

Roth Capital reiterated a Buy rating on MaxLinear (NYSE: MXL), and raised the price target to $21.00 (from $17.00), following the company's 3Q earnings report. MXL reported good 3Q15 results with revenues/proforma EPS of $95.2 million/$0.40 versus Roth Capital's $95.0 million/$0.34 estimates.

Analyst Krishna Shankar commented, "Following the positive pre-announcement, MXL reported good 3Q15 results with revenues/proforma EPS of $95.2 million/$0.40 versus our $95.0 million/$0.34 estimates and guided to 3% sequential revenues (versus prior flat outlook). We view MXL as an attractive investment theme with good organic growth and targeted accretive acquisitions such as Entropic and PHYSpeed in the connected broadband home and communications/ networking infrastructure market. We raise our estimates and target price and reiterate Buy rating."

For an analyst ratings summary and ratings history on MaxLinear click here. For more ratings news on MaxLinear click here.

Shares of MaxLinear closed at $13.13 yesterday.

You May Also Be Interested In

• Range Resources (RRC) PT Raised to $41 at Mizuho
• H.C. Wainwright Downgrades Argo Blockchain ADR (ARBK) to Neutral
• Sage Therapeutics (SAGE) PT Lowered to $18 at Mizuho